Davis Polk advised Silver Spike Acquisition Corp. II on the deal, while Latham & Watkins represented Eleusis. Silver Spike Acquisition Corp. II announced its approximately $446...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Mesoblast in the transaction. Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in stem cell medicines for inflammatory diseases, has announced that it has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Avellum advised DTEK Energy on the deal, Hogan Lovells and Asters advised an unidentified group of ad hoc lenders on the matter....
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Cains and Bedell Cristin advised Tullow Oil on the deal. Ogier worked alongside Vinson & Elkins as lead counsel to the initial purchasers...
You must be a Standard 1 Year member to access this content.
